Pharmacoeconomic series: Part 3. Applying pharmacoeconomic and quality-of-life measures to the formulary management process.
P & T Committees were established as an institution's primary organizational tool for the development and maintenance of the formulary. Traditionally, P & T Committees have focused on the safety, efficacy, and acquisition cost of medications to be considered for formulary approval. Today, the impact of pharmaceuticals on patients' quality-of-life and total health care expenditures are increasingly important considerations to be weighed by P & T Committees. Pharmacoeconomic analyses and quality-of-life outcomes represent valuable contributions to the formulary decision-making and management process.
Skaer
T L
TL
College of Pharmacy, Washington State University, Pullman 99164.
D000900:Anti-Bacterial Agents / Q000008:administration & dosage / Q000191:economics; D003362:Cost-Benefit Analysis; D003659:Decision Making, Organizational; D004333:Drug Administration Routes; D005572:Formularies, Hospital as Topic / Q000592:standards*; D017408:Guidelines as Topic; D006801:Humans; D006973:Hypertension / Q000188:drug therapy; D017053:Infection Control / Q000191:economics; D010146:Pain / Q000188:drug therapy; D010606:Pharmacy and Therapeutics Committee; D011788:Quality of Life; D014481:United States